Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Hong Kong · Delayed Price · Currency is HKD 34.94
-0.40 (-1.13%)
Sep 23, 2026, 4:08 PM HKT
HKG:3692 Stock Forecast
Stock Price Forecast
According to 24 analysts polled by S&P Global, HKG:3692 stock has a consensus rating of "Strong Buy" and an average price target of $47.79. The average 1-year stock price forecast is 36.78% higher than the current stock price, while the lowest is $37.35 (+6.90%) and the highest is $55.21 (+58.01%).
Price Target: $47.79 (+36.78%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HKG:3692 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 18 | 16 | 16 | 16 | 18 | 19 |
| Buy | 5 | 5 | 5 | 5 | 5 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 25 | 22 | 22 | 22 | 24 | 24 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Guosheng Securities No rating | Guosheng Securities | Buy Maintains $40.61 → $40.89 | Buy | Maintains | $40.61 → $40.89 | +17.03% | Sep 11, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $48.80 → $50.80 | Buy | Maintains | $48.80 → $50.80 | +45.39% | Sep 8, 2026 |
Unknown Analyst Zhongtai Securities No rating | Zhongtai Securities | Buy Maintains $48.80 | Buy | Maintains | $48.80 | +39.67% | Sep 4, 2026 |
Unknown Analyst China Renaissance No rating | China Renaissance | Buy Maintains $45.51 | Buy | Maintains | $45.51 | +30.25% | Sep 3, 2026 |
| CMB International Securities | CMB International Securities | Buy Maintains $47.19 → $49.12 | Buy | Maintains | $47.19 → $49.12 | +40.58% | Aug 29, 2026 |
Financial Forecast
Revenue This Year
17.00B
from 15.03B
Increased by 13.09%
Revenue Next Year
18.64B
from 17.00B
Increased by 9.69%
EPS This Year
1.07
from 0.93
Increased by 15.13%
EPS Next Year
1.12
from 1.07
Increased by 4.99%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.